000 01626 a2200397 4500
005 20250517064541.0
264 0 _c20160317
008 201603s 0 0 eng d
022 _a1879-0852
024 7 _a10.1016/j.ejca.2015.08.030
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarton, Sarah
245 0 0 _aThe influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cDec 2015
300 _a2732-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aClinical Trials, Phase III as Topic
_xeconomics
650 0 4 _aData Interpretation, Statistical
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aGastroenterology
_xeconomics
650 0 4 _aGastrointestinal Neoplasms
_xpathology
650 0 4 _aHumans
650 0 4 _aMedical Oncology
_xeconomics
650 0 4 _aRandomized Controlled Trials as Topic
_xeconomics
650 0 4 _aResearch Design
_xstatistics & numerical data
650 0 4 _aResearch Report
650 0 4 _aResearch Support as Topic
_xeconomics
650 0 4 _aSample Size
650 0 4 _aTreatment Outcome
700 1 _aPeckitt, Clare
700 1 _aSclafani, Francesco
700 1 _aCunningham, David
700 1 _aChau, Ian
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 51
_gno. 18
_gp. 2732-9
856 4 0 _uhttps://doi.org/10.1016/j.ejca.2015.08.030
_zAvailable from publisher's website
999 _c25486618
_d25486618